Lichawska-Cieslar A, Szukala W, Ylla G, Machaj G, Ploskonka F, Chlebicka I
J Exp Clin Cancer Res. 2024; 43(1):290.
PMID: 39428471
PMC: 11492624.
DOI: 10.1186/s13046-024-03211-8.
Kwon H, Lee S, Han Y, Lee J, Kwon S, Kim H
Cancer Res Treat. 2023; 56(2):442-454.
PMID: 37973906
PMC: 11016656.
DOI: 10.4143/crt.2023.764.
Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T
Front Immunol. 2022; 13:939836.
PMID: 35898512
PMC: 9309259.
DOI: 10.3389/fimmu.2022.939836.
Khalid Z, Khan A, Alnajjar R, Santali E, Shakoori A
Sci Rep. 2022; 12(1):7798.
PMID: 35552474
PMC: 9098448.
DOI: 10.1038/s41598-022-11805-5.
Luo S, Lin R, Liao X, Li D, Qin Y
Sci Rep. 2021; 11(1):23674.
PMID: 34880371
PMC: 8655011.
DOI: 10.1038/s41598-021-03086-1.
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma.
Valencia K, Sainz C, Bertolo C, de Biurrun G, Agorreta J, Azpilikueta A
Dis Model Mech. 2021; 15(1).
PMID: 34870316
PMC: 8822220.
DOI: 10.1242/dmm.049137.
CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients.
Lu N, Liu J, Xu M, Liang J, Wang Y, Wu Z
Int J Gen Med. 2021; 14:7647-7657.
PMID: 34764678
PMC: 8575319.
DOI: 10.2147/IJGM.S335592.
Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression.
Pecora A, Laprise J, Dahmene M, Laurin M
Cancers (Basel). 2021; 13(17).
PMID: 34503171
PMC: 8431333.
DOI: 10.3390/cancers13174362.
Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
Aiderus A, Newberg J, Guzman-Rojas L, Contreras-Sandoval A, Meshey A, Jones D
PLoS Genet. 2021; 17(8):e1009094.
PMID: 34398873
PMC: 8389471.
DOI: 10.1371/journal.pgen.1009094.
Regulation of the Phosphoinositide Code by Phosphorylation of Membrane Readers.
Kervin T, Overduin M
Cells. 2021; 10(5).
PMID: 34069055
PMC: 8156045.
DOI: 10.3390/cells10051205.
Recent advances in preclinical models for lung squamous cell carcinoma.
Pan Y, Han H, Labbe K, Zhang H, Wong K
Oncogene. 2021; 40(16):2817-2829.
PMID: 33707749
DOI: 10.1038/s41388-021-01723-7.
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies.
Jaganjac M, Milkovic L, Sunjic S, Zarkovic N
Antioxidants (Basel). 2020; 9(11).
PMID: 33228209
PMC: 7699519.
DOI: 10.3390/antiox9111151.
Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort.
Mangalaparthi K, Patel K, Khan A, Manoharan M, Karunakaran C, Murugan S
Front Oncol. 2020; 10:1457.
PMID: 32974170
PMC: 7469928.
DOI: 10.3389/fonc.2020.01457.
Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.
Dutta M, Nakagawa H, Kato H, Maejima K, Sasagawa S, Nakano K
PeerJ. 2020; 8:e9294.
PMID: 32617189
PMC: 7323713.
DOI: 10.7717/peerj.9294.
Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation.
Gong M, Li Y, Ye X, Zhang L, Wang Z, Xu X
Cell Commun Signal. 2020; 18(1):98.
PMID: 32576270
PMC: 7310414.
DOI: 10.1186/s12964-020-00568-z.
G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F, Al-Ejeh F, Miranda M, Kelly G, Baxter E, Windloch K
Theranostics. 2020; 10(10):4515-4529.
PMID: 32292512
PMC: 7150496.
DOI: 10.7150/thno.41453.
Structure and regulation of human epithelial cell transforming 2 protein.
Chen M, Pan H, Sun L, Shi P, Zhang Y, Li L
Proc Natl Acad Sci U S A. 2020; 117(2):1027-1035.
PMID: 31888991
PMC: 6969500.
DOI: 10.1073/pnas.1913054117.
Unraveling cancer lineage drivers in squamous cell carcinomas.
Guan Y, Wang G, Fails D, Nagarajan P, Ge Y
Pharmacol Ther. 2019; 206:107448.
PMID: 31836455
PMC: 6995404.
DOI: 10.1016/j.pharmthera.2019.107448.
Mutational landscape of head and neck squamous cell carcinomas in a South Asian population.
Ghias K, Rehmani S, Razzak S, Madhani S, Azim M, Ahmed R
Genet Mol Biol. 2019; 4242(3):526-542.
PMID: 31188922
PMC: 6905448.
DOI: 10.1590/1678-4685-GMB-2018-0005.
Two-edged sword: how activation of the "proto-oncogene" yes-associated protein 1 in lung squamous cell carcinoma can surprisingly inhibit tumor growth.
Andl T, Andl C, Zhang Y
J Thorac Dis. 2019; 10(Suppl 33):S3870-S3874.
PMID: 30631502
PMC: 6297518.
DOI: 10.21037/jtd.2018.10.11.